Estrogens and Parkinson disease: Novel approach for neuroprotection

Endocrine

Volumn 21, Issue 1, 2003, Pages 77-79

  Sawada, Hideyuki ^a   Shimohama, Shun ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Dopaminergic neuron; Estrogen receptor; Oxidative stress; Selective estrogen receptor modulator

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; CATECHOL METHYLTRANSFERASE INHIBITOR; CONJUGATED ESTROGEN; DOPAMINE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; GENISTEIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTATHIONE; NEUROTROPHIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; RALOXIFENE; TAMOXIFEN; TRANSCRIPTION FACTOR AP 1;

AGING; ANTIOXIDANT ACTIVITY; APOPTOSIS; BINDING AFFINITY; BREAST CANCER; CANCER RISK; CLINICAL FEATURE; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ESTROGEN ACTIVITY; ESTROGEN BINDING; ESTROGEN BLOOD LEVEL; ESTROGEN RESPONSIVE ELEMENT; ESTROGEN THERAPY; FEMINIZATION; GENETIC DISORDER; HORMONE STRUCTURE; HUMAN; LIGAND BINDING; LOW DRUG DOSE; MOTOR DYSFUNCTION; NERVE CELL CULTURE; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; PARKINSON DISEASE; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PUTAMEN; REVIEW; SECOND MESSENGER; SEX DIFFERENCE; SIDE EFFECT; STRIA TERMINALIS; TRANSCRIPTION REGULATION; UPREGULATION; UTERUS CANCER;

EID: 0037606099     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1385/ENDO:21:1:77     Document Type: Review

References (41)

1. Nurmi, E., Ruottinen, H. M., Kaasinen, V., et al. (2000). Ann. Neurol. 47, 804-808.
2. Pirker, W., Djamshidian, S., Asenbaum, S., et al. (2001). Mov. Disord. 17, 45-53.
3. Bauer, R. B., Stevens, C., Reveno, W. S., and Rosenbaum, H. (1982). J. Am. Geriatr. Soc. 30, 322-325.
4. Li, S. C., Schoenberg, B. S., Wang, C. C., et al. (1985). Arch. Neurol. 42, 655-657.
5. Jankovic, J. and Kapadia, A. S. (2001). Arch. Neurol. 58, 1611-1615.
6. Leranth, C., Roth, R. H., Elswoth, J. D., Naftolin, F., Horvath, T. L., and Redmond, J. D. E. (2000). J. Neurosci. 20, 8604-8609.
7. Mooradian, A. D. (1993). J. Steroid Biochem. Mol. Biol. 45, 509-511.
8. Negre Salvayre, A., Pieraggi, M. T., Mabile, L., and Salvayre, R. (1993). Atherosclerosis 99, 207-217.
9. Rifici, V. A. and Khachadurian, A. K. (1992). Metabolism 41, 1110-1114.
10. Keller, J. N., Germeyer, A., Begley, J. G., and Mattson, M. P. (1997). J. Neurosci. Res. 50, 522-530.
11. Behl, C., Skutella, T., Lezoualc'h, F., et al. (1997). Mol. Pharmacol. 51, 535-541.
12. Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Akaike, A., and Shimohama, S. (1998). J. Neurosci. Res. 54, 707-719.
13. Gridley, K. E., Green, P. S., and Simpkins, J. W. (1998). Mol. Pharmacol. 54, 874-880.
14. Ambani, L. M., Van Woert, M. H., and Murphy, S. (1975). Arch. Neurol. 32, 114-118.
15. Perillo, B., Sasso, A., Abbondanza, C., and Palumbo, G. (2000). Mol. Cell. Biol. 20, 2890-2901.
16. Honda, K., Sawada, H., Kihara, T., et al. (2000). J. Neurosci. Res. 60, 321-327.
17. Honda, K., Shimohama, S., Sawada, H., et al. (2001). J. Neurosci. Res. 64, 466-475.
18. Lee, S. J. and McEwen, B. S. (2001). Annu. Rev. Pharmacol. Toxicol. 41, 569-591.
19. Simpkins, J. W., Green, P. S., Gridley, K. E., Singh, M., de Fiebre, N. C., and Rajakumar, G. (1997). Am. J. Med. 103, 19S-25S.
20. Ivanova, T., Karolczak, M., and Beyer, C. (2002). Endocrinology 143, 3175-3178.
21. Xie, T., Ho, S. L., and Ramsden, D. (1999). Mol. Pharmacol. 56, 31-38.
22. Tsang, K. L., Ho, S. L., and Lo, S. K. (2000). Neurology 54, 2292-2298.
23. Burns, R. S., Chiueh, C. C., Markey, S. P., Ebert, M. H., Jacobowitz, D. M., and Kopin, I. J. (1983). Proc. Natl. Acad. Sci. USA 80, 4546-4550.
24. Langston, J. W., Ballard, P., Tetrud, J. W., and Irwin, I. (1983). Science 219, 979-980.
25. Naoi, M., Maruyama, W., Dostert, P., and Hashizume, Y. (1997). J. Neural Transm. 50(Suppl.), 89-105.
26. Maruyama, W., Strolin-Benedetti, M., and Naoi, M. (2000). Neurobiology 8, 55-68.
27. Ramsay, R. R., Salach, J. I., and Singer, T. P. (1986). Biochem. Biophys. Res. Commun. 134, 743-748.
28. Mizuno, Y., Sone, N., and Saitoh, T. (1987). J. Neurochem. 48, 1787-1793.
29. Gelinas, S. and Martinoli, M. G. (2002). J. Neurosci. Res. 70, 90-96.
30. Sawada, H., Ibi, M., Kihara, T., et al. (2002). Neuropharmacology 42, 1056-1064.
31. Callier, S., Le Saux, M., Lhiaubet, A. M., Di Paolo, T., Rostene, W., and Pelaprat, D. (2002). J. Neurochem. 80, 307-316.
32. Grandbois, M., Morissette, M., Callier, S., and Di Paolo, T. (2000). Neuroreport 11, 343-346.
33. Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J. A. (1996). Proc. Natl. Acad. Sci. USA 93, 5925-5930.
34. Shughrue, P. J., Lane, M. V., and Merchenthaler, I. (1997). J. Comp. Neurol. 388, 507-525.
35. Kuiper, G. G., Carlsson, B., Grandien, K., et al. (1997). Endocrinology 138, 863-870.
36. Barkhem, T., Carlsson, B., Nilsson, Y., Enmark, E., Gustafsson, J., and Nilsson, S. (1998). Mol. Pharmacol. 54, 105-112.
37. Paech, K., Webb, P., Kuiper, G. G., et al. (1997). Science 277, 1508-1510.
38. Qiu, Y., Waters, C. E., Lewis, A. E., Langman, M. J., and Eggo, M. C. (2002). J. Endocrinol. 174, 369-377.
39. Kim, H. T., Kim, B. C., Kim, I. Y., et al. (2002). J. Biol. Chem. 277, 32510-32515.
40. Sawada, H., Ibi, M., Kihara, T., et al. (2000). FASEB J. 14, 1202-1214.
41. Linford, N. J. and Dorsa, D. M. (2002). Steroids 67, 1029-1040.